Status:
UNKNOWN
Mindfulness Meditation for Epilepsy
Lead Sponsor:
Rennes University Hospital
Collaborating Sponsors:
Laboratoire Traitement du Signal et de l'Image, INSERM UMR1099 Rennes
Centre Hospitalier Guillaume Régnier, RENNES
Conditions:
Epilepsy
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
In one-third of epileptic patients treated in France, seizures persist despite drug treatment. These so-called "refractory" epilepsies are among the most severe. Only a minority of patients with refra...
Detailed Description
Through the development of standardized protocols, mindfulness meditation has been introduced as a complementary treatment to prevent the relapse of depression, and to reduce stress and improve well-b...
Eligibility Criteria
Inclusion
- For patients :
- Patients over 16 years of age;
- Epilepsy refractory to drug treatment according to the consensus criteria of the International League Against Epilepsy ;
- Affiliated with a health insurance plan;
- Free, informed and written consent signed by the patient, and parents for patients under the age of 18.
- For healthy subjects :
- Healthy subjects 16 years of age and older;
- Affiliated with a health insurance plan;
- Free, informed and written consent signed by the volunteer, or parents, for volunteers under the age of 18.
Exclusion
- For patients :
- Alcohol Addiction Disorders (assessed by the Mini-International Neuropsychiatric Interview (MINI) scale) ;
- Patients with psychogenic crises;
- Treatment with antidepressants;
- Simultaneous participation in other research that may interfere with the protocol;
- Persons of legal age subject to legal protection (safeguard of justice, curatorship, guardianship), persons deprived of liberty.
- For healthy subjects :
- Psychiatric pathology and/or alcohol addiction disorders (evaluated by the MINI scale) ;
- Simultaneous participation in other research that may interfere with the protocol;
- Persons of legal age subject to legal protection (protection of justice, guardianship, trusteeship), persons deprived of liberty.
Key Trial Info
Start Date :
January 14 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 15 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04687904
Start Date
January 14 2021
End Date
March 15 2023
Last Update
December 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire
Rennes, France, 35033